Stabilization and augmentation of circulating AIM in mice by synthesized IgM-Fc

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Kai, Toshihiro ^a   Yamazaki, Tomoko ^a   Arai, Satoko ^a   Miyazaki, Toru ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR OF MACROPHAGE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN J CHAIN; IMMUNOGLOBULIN M; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CD5L PROTEIN, MOUSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; INTRAABDOMINAL FAT; MOUSE; NONHUMAN; OBESITY; URINARY EXCRETION; ANIMAL; APOPTOSIS; BIOSYNTHESIS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOLOGY;

ADIPOCYTES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTRA-ABDOMINAL FAT; MACROPHAGES; MICE; OBESITY; RECEPTORS, IMMUNOLOGIC;

EID: 84900548058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097037     Document Type: Article

References (39)

1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808. (Pubitemid 38063703)
2. Xu H, Barnes GT, Yang Q, Tan G, Yang D et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830. (Pubitemid 38063705)
3. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL et al. (2007) JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 6: 386-297.
4. Hotamisligil GS, Shargill NS, Spiegelman BM. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91. (Pubitemid 23036092)
5. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198. (Pubitemid 40321355)
6. Neels JG, Olefsky JM (2006) Inflamed fat: what starts the fire? J Clin Invest 116: 33-35. (Pubitemid 43121788)
7. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793-1801. (Pubitemid 44033299)
8. Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788. (Pubitemid 38063699)
9. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
10. Day C P, Saksena S (2002) Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol 17 Suppl 3: S377-S384. (Pubitemid 35454314)
11. Harrison S A, Torgerson S, Hayashi P H (2003) The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98: 2042-2047. (Pubitemid 37185803)
12. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW et al. (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11: 74-80. (Pubitemid 20075105)
13. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF et al. (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51: 1972-1978.
14. Blonski W, Kotlyar DS, Forde KA (2010) Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 16: 3603-3015.
15. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576. (Pubitemid 46890874)
16. Nordenstedt H, White D L, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 42 Suppl 3: S206-214.
17. Rosenbloom AL (2003) Obesity, Insulin Resistance, beta-Cell Autoimmunity, and the Changing Clinical Epidemiology of Childhood Diabetes. Diabetes Care 26: 2954-2956.
18. Hersoug LG, Linneberg A (2007) The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy 62: 1205-1213.
19. Cambuli VM, Incani M, Cossu E, Congiu T, Scano F et al. (2010) Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children. Diabetes Care 33: 820-822.
20. Marzullo P, Minocci A, Tagliaferri MA, Guzzaloni G, Di Blasio A et al. (2010) Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab 95: 3965-3972.
21. Badaru A, Pihoker C (2012) Type 2 Diabetes in Childhood: Clinical Characteristics and Role of b-Cell Autoimmunity. Curr Diab Rep 12: 75-81.
22. Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K et al. (2013) Obesity-associated autoantibody production requires AIM to retain IgM immune complex on follicular dendritic cells. Cell Rep 3: 1187-1198.
23. Moulin CM, Marguti I, Peron JP, Rizzo LV, Halpern A (2009) Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metabol. 53: 18318-9.
24. Miyazaki T, Hirokami Y, Matsuhashi N, Takatsuka H, Naito M (1999) Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med 189: 413-422. (Pubitemid 29063262)
25. Kurokawa J, Arai S, Nakashima K, Nishijima A, Miyake K et al. (2010) AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab 11: 479-492.
26. Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA et al. (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119: 299-309. (Pubitemid 39360910)
27. Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D, Karin M et al. (2004) Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 101: 17813-17818. (Pubitemid 40051969)
28. Arai S, Shelton JM, Chen M, Bradley MN, Castrillo A et al. (2005) A role of the apoptosis inhibitory factor AIM/Sp a/Api6 in atherosclerosis development. Cell Metab 1: 201-213. (Pubitemid 43960602)
29. Gangadharan B, Antrobus R, Dwek RA, Zitzmann N (2007) Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin. Chem. 53, 1792-1799. (Pubitemid 47509672)
30. Gebe JA, Kiener PA, Ring HZ, Li X, Francke U et al. (1997) Molecular cloning, mapping to human chromosome 1 q21-q23, and cell binding characteristics of Spalpha, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteins. J Biol Chem 272: 6151-6158. (Pubitemid 27118082)
31. Gebe JA, Llewellyn M, Hoggatt H, Aruffo A (2000) Molecular cloning, genomic organization and cell-binding characteristics of mouse Spalpha. Immunology 99: 78-86. (Pubitemid 30062941)
32. Gray J, Chattopadhyay D, Beale GS, Patman GL, Miele L et al. (2009) A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer 9: 271.
33. Kim WK, Hwang HR, Kim do H, Lee PY, In YJ et al. (2008) Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers. Exp Mol Med 40: 677-685.
34. Mori M, Kimura H, Iwamura Y, Arai S, Miyazaki T (2012) Modification of N-glycosylation modulates the secretion and lipolytic function of Apoptosis Inhibitor of Macrophage (AIM). FEBS Lett 586: 3569-3574.
35. Iwamura Y, Mori M, Nakashima K, Mikami T, Murayama K et al. (2012) Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes. Biochem Biophys Res Commun 422: 476-481.
36. Kurokawa J, Nagano H, Ohara O, Kubota N, Kadowaki T, et al. (2011) AIM is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue. Proc Natl Acad Sci U SA 108: 12072-12077.
37. Tissot JD, Sanchez JC, Vuadens F, Scherl A, Schifferli JA et al. (2002) IgM are associated to Sp alpha (CD5 antigen-like). Electrophoresis 23: 1203-1206.
38. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M et al. (1998) Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 160: 4776-4787. (Pubitemid 28215311)
39. Säfsten P, Klakamp SL, Drake AW, Karlsson R, Myszka DG (2006) Screening antibody-antigen interactions in parallel using Biacore A100. Anal Biochem 353: 181-190. (Pubitemid 43775424)